Home Influence of haemodialysis on the NT-proBNP plasma concentration
Article
Licensed
Unlicensed Requires Authentication

Influence of haemodialysis on the NT-proBNP plasma concentration

  • Giuseppe Lippi , Nicola Tessitore , Gian Luca Salvagno , Martina Montagnana , Antonio Lupo and Gian Cesare Guidi
Published/Copyright: October 10, 2007
Become an author with De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 45 Issue 10

Published Online: 2007-10-10
Published in Print: 2007-10-01

©2007 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Atrial natriuretic peptide and related peptides
  2. The −374A allele of the receptor for advanced glycation end products (RAGE) gene promoter is a protective factor against cardiovascular lesions in type 2 diabetes mellitus patients
  3. Biochemical properties of endogenous presenilin 1 and presenilin 2 in cultured human B-lymphocytes
  4. CD36 polymorphism and its relationship with body mass index and coronary artery disease in a Korean population
  5. Preservation of RNA for functional analysis of separated alleles in yeast: comparison of snap-frozen and RNALater® solid tissue storage methods
  6. Mother-child double incompatibility at vWA and D5S818 loci in paternity testing
  7. Matrix metalloprotease-2 and -9 concentration and activity in serum and culture medium samples: a methodological reappraisal
  8. Are changes in blood-ethanol concentration during storage analytically significant? Importance of method imprecision
  9. Measurement of arginine derivatives in pediatric patients with chronic kidney disease using high-performance liquid chromatography-tandem mass spectrometry
  10. The soluble transferrin receptor reflects tumor load in chronic lymphocytic leukemia
  11. Calculated low-density lipoprotein cholesterol remains a viable and important test for screening and targeting therapy
  12. Angiotensin-converting enzyme (ACE) I/D corrected serum ACE activity and severity assessment of community-acquired pneumonia
  13. Differentiating transudative from exudative pleural effusion: should we measure effusion cholesterol dehydrogenase?
  14. Association of classical and related inflammatory markers with high-sensitivity C-reactive protein in healthy individuals: results from the Stanislas cohort
  15. Cytokines and growth factors in mostly atherosclerotic patients on hemodialysis determined by biochip array technology
  16. Use of a solid-phase extraction with radioimmunoassay to identify the proportional bias of clinical B-type natriuretic peptide immunoassay: the impact of plasma matrix and antibody multispecificity
  17. High plasma levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) and interleukin-8 (IL-8) characterize patients prone to ventricular fibrillation complicating myocardial infarction
  18. Methylprednisolone, cortisol and the cell-mediated immune response in children after ventricular septal defect repair
  19. Standardization of γ-glutamyltransferase assays by intermethod calibration. Effect on determining common reference limits
  20. The effect of endurance exercise-induced lactacidosis on biochemical markers of bone turnover
  21. Serum biobank certification and the establishment of quality controls for biological fluids: examples of serum biomarker stability after temperature variation
  22. Diagnostic usefulness of a third-generation anti-cyclic citrulline antibody test in patients with recent-onset polyarthritis
  23. Clinical significance of the laboratory determination of low serum copper in adults
  24. National survey on critical values reporting in a cohort of Italian laboratories
  25. Influence of haemodialysis on the NT-proBNP plasma concentration
  26. C–588T polymorphism of the human glutamate-cysteine ligase modifier subunit gene is not associated with the risk and extent of ischemic heart disease in a German cohort
  27. Has homocysteine shrunk?
Downloaded on 10.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2007.280/html
Scroll to top button